G&E Herbal Biotechnology Co., Ltd. logo

G&E Herbal Biotechnology Co., Ltd. (4911)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
28. 25
-0.25
-0.8772%
NT$
3.2B Market Cap
- P/E Ratio
2.28% Div Yield
8,260 Volume
- Eps
NT$ 28.5
Previous Close
Add Transaction
Day Range
28.25 28.5
Year Range
27.9 52.41
Want to track 4911 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4911 closed today lower at NT$28.25, a decrease of -0.8772% from yesterday's close, completing a monthly decrease of -1.5806% or -NT$0.45. Over the past 12 months, 4911 stock lost -34.3023%.
4911 pays dividends to its shareholders, with the most recent payment made on Aug 21, 2025. The next announced payment will be in In 1 weeks on Aug 20, 2026 for a total of NT$1.2594.
G&E Herbal Biotechnology Co., Ltd. has completed 4 stock splits, with the recent split occurring on Jul 28, 2026.
The company's stock is traded on one exchange.

4911 Chart

People also search for

Ch Biotech R&D Co. Ltd.
NT$ 93.7
0%
United Orthopedic Corporation
NT$ 86.4
+0.4651%
Adimmune Corp
NT$ 17.4
-0.8547%
TaiGen Biopharmaceuticals Holdings Limited
NT$ 9.02
+3.6782%
Huxen Corp
NT$ 41.9
0%

G&E Herbal Biotechnology Co., Ltd. (4911) FAQ

What is the stock price today?

The current price is NT$28.25.

On which exchange is it traded?

G&E Herbal Biotechnology Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4911.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.28%.

What is its market cap?

As of today, the market cap is 3.2B.

Has G&E Herbal Biotechnology Co., Ltd. ever had a stock split?

G&E Herbal Biotechnology Co., Ltd. had 4 splits and the recent split was on Jul 28, 2026.

G&E Herbal Biotechnology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Kou-Wha Kou Ph.D. CEO
TWSE Exchange
TW0004911003 ISIN
Taiwan Country
37 Employees
28 Jul 2026 Last Dividend
28 Jul 2026 Last Split
- IPO Date

Overview

G&E Herbal Biotechnology Co., Ltd. is a pioneering biotechnology firm based in Tainan City, Taiwan, established in 2002. This company dedicates its efforts to the advancement and commercialization of innovative botanical extraction technologies and products. Its broad range of research and product development encompasses areas such as chronic liver diseases, cosmetic anti-aging solutions, skin repair, healthcare supplements, and cancer treatments. In addition to manufacturing, G&E Herbal Biotechnology also extends its expertise through technical advisory services, affirming its role as a key player in the biotechnological and healthcare industries in Taiwan.

Products and Services

  • Hepato protective agent capsules:

    These capsules are designed for patients suffering from chronic liver inflammation, cirrhosis, hepatitis, and other liver-related issues, offering a botanical-based therapeutic alternative.

  • Botanical anti-aging cosmetic products:

    This range includes foam cleanser, botanical extract toner, moisture conditioning cream, and whitening clear cream, all aimed at offering natural solutions for anti-aging skincare.

  • SR-100 skin repair gel:

    A specialized gel for skin repair, helping with the recovery of damaged skin and enhancing skin health and vitality.

  • Botanical healthcare products:

    G&E offers a variety of health supplements addressed to improve overall well-being and target specific health issues. These include:

    • ArthrEnergy (for joint and muscle health)
    • Jujubes Polysaccharide (boosts immunity)
    • Diabecut (supports blood sugar control)
    • HepatoClean (liver detoxification)
    • Astragali Radix, Goji, and Prosta (traditional herbs with various health benefits)
    • SR-100 capsules (for skin health)

  • Adult products:

    The company extends its product range to include adult specific health supplements, focusing on areas such as vitality and wellness.

  • Developing treatments:

    G&E Herbal Biotechnology is actively engaged in the development of innovative treatments for cancer and skin conditions. These include:

    • Solarise injection (aimed at treating gynecological, head, and neck cancers)
    • Apocin capsule (for the treatment of non-small cell lung cancer)
    • SR-T100 Gel (focused on treating common and genital warts)

  • Technology development and advisory services:

    Aside from their product lines, G&E Herbal Biotechnology is also involved in the development of technology for dietary supplements and offers technical advisory services to other entities within the biotechnology sphere, showcasing their commitment to innovation and support within the industry.

Contact Information

Address: No.92, Keji 5th Road
Phone: 886 6 384 0890